Nitrosated and nitorsylated alpha-andrenergic receptor antagonist compounds, compositions and their uses
    2.
    发明公开
    Nitrosated and nitorsylated alpha-andrenergic receptor antagonist compounds, compositions and their uses 失效
    亚硝化和亚硝基化andrenergische的α-受体拮抗剂化合物,它们的组合物,及其用途

    公开(公告)号:EP1852422A2

    公开(公告)日:2007-11-07

    申请号:EP07011814.6

    申请日:1997-01-28

    申请人: Nitromed, Inc.

    摘要: Disclosed are nitrosated and nitrosylated α-adrenergic receptor antagonists, compositions of an α-adrenergic receptor antagonist (α-antagonist), which can optionally be substituted with at least one NO or NO 2 moiety, and a compound that donates, transfers or releases nitric oxide as a charged species, i.e., nitrosonium (NO + ) or nitroxyl (NO - ), or as the neutral species, nitric oxide (NO.); and uses for each of them in treating human impotence or erectile dysfunction.

    摘要翻译: 本发明公开了亚硝化和亚硝酰化±肾上腺素能受体拮抗剂,一个±肾上腺素能受体拮抗剂的组合物(±拮抗剂),其可以与至少一种的NO或NO 2基团的化合物,以及任选地被substituiertem做捐赠,转移或释放一 氧化物作为带电物质,即,亚硝鎓(NO +)或硝酰基(NO - ),或作为中性物质,一氧化氮(NO); 并在治疗人类阳痿或勃起功能障碍的用途为他们每个人。